跳转至内容
Merck
CN

662056

泛素醛

≥95% (HPLC), liquid, ubiquitin hydrolase inhibitor, Calbiochem®

别名:

ubiquitin hydrolase inhibitor

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352200
NACRES:
NA.77
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

泛素醛, Potent and specific inhibitor of multiple ubiquitin hydrolases involved in pathways of intracellular protein modification and turnover.

assay

≥95% (HPLC)

form

liquid

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze

solubility

DMSO: 50 mg/mL
aqueous buffer: soluble

shipped in

ambient

storage temp.

−20°C

Quality Level

Biochem/physiol Actions

主要靶标
多种泛素水解酶(参与细胞内蛋白质修饰和转换途径)
产物不与ATP竞争。
可逆:否
显示抑制异肽酶T(目录号419700)和泛素C末端水解酶(目录号662090)的活性
细胞可渗透性:否

Disclaimer

毒性:标准处理(A)

General description

多种泛素水解酶(参与细胞内蛋白质修饰和转换途径)的有效和特异性抑制剂。用于稳定内源性或体外合成的泛素-蛋白质偶联物。也可用于提高或降低泛素依赖性降解速率。

Other Notes

Melandri, F., et al. 1996.Biochemistry 35, 12893.
Shaeffer, J.R. and Cohen, R.E.1996.Biochemistry 35, 10886.
Pickart, C.M. and Rose, I.A.1986.J. Biol. Chem. 261, 10210.

Packaging

特定浓度批号请参考小瓶的标签。

Physical form

在150 mM HCL中。

Preparation Note

复溶后,等分并冷冻保存(-20°C)。

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

存储类别

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Mengmeng Niu et al.
PLoS biology, 19(2), e3001113-e3001113 (2021-02-25)
Transforming growth factor-β (TGF-β) signaling plays a critical role in promoting epithelial-to-mesenchymal transition (EMT), cell migration, invasion, and tumor metastasis. ΔNp63α, the major isoform of p63 protein expressed in epithelial cells, is a key transcriptional regulator of cell adhesion program
Mengmeng Niu et al.
Nature communications, 12(1), 5919-5919 (2021-10-13)
Abnormal activation of epidermal growth factor receptor (EGFR) drives non-small cell lung cancer (NSCLC) development. EGFR mutations-mediated resistance to tyrosine-kinase inhibitors (TKIs) is a major hurdle for NSCLC treatment. Here, we show that F-box protein FBXL2 targets EGFR and EGFR

相关内容

Select different protease inhibitor types based on your needs to prevent protein degradation during isolation and characterization and safeguard proteins in sample prep.

查看所有结果

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持